Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

Author： Berendsen Sharon   Broekman Marike   Seute Tatjana   Snijders Tom   van Es Corine   de Vos Filip   Regli Luca   Robe Pierre  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.9, 2012-09, pp. : 1391-1415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 422-427

Bentham Science Publishers

Access to resources Recommend Favorite

Valproic Acid in the Complex Therapy of Malignant Tumors

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 361-379

Bentham Science Publishers

Access to resources Recommend Favorite

Pramlintide for the Treatment of Insulin-Requiring Diabetes Mellitus: Rationale and Review of Clinical Data

By Kruger D.F.  

Drugs, Vol. 64, Iss. 13, 2004-01 ,pp. : 1419-1432

Adis International

Access to resources Recommend Favorite

The treatment of psoriasis with IL-10: rationale and review of the first clinical trials

By Asadullah K.   Döcke W-D.   Sabat R.   Volk H-D.   Sterry W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 95-102

Informa Healthcare

Access to resources Recommend Favorite

Nucleic Acid-based Technologies in Therapy of Malignant Gliomas

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1805-1822

Bentham Science Publishers

Access to resources Recommend Favorite